As clinical specimen analysis revealed both that CamK-A was highly expressed in tumor tissues versus adjacent normal tissues and that its high expression was associated with poor clinical outcomes of patients with breast cancer, Sang et al. examined the role of CamK-A in tumorigenesis using a patient-derived xenograft model (PDX) of TNBC. This evidence concerns the gene CAMK2A and breast carcinoma.